A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples